Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).
- Citation:
- J Clin Oncol vol 42 (24) 2853-9
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 13
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA189830, UG1CA189954, UG1CA233290, UG1CA233180, UG1CA233337, UG1CA233339; U10CA180863, CCS 707213 (CCTG); U10CA180794, U10CA180820, UG1CA233234 (ECOG-ACRIN); U10CA180868 (NRG Oncology); U10CA180888. UG1CA233163 (SWOG)
- Corr. Author:
- Authors:
- Jonathan A Nowak Tyler Twombly Chao Ma Qian Shi Koichiro Haruki Kenji Fujiyoshi Juha Väyrynen Melissa Zhao James Knight Shrikant Mane Ardaman Shergill Pankaj Kumar Felix Couture Philip Kuebler Smitha Krishnamurthi Benjamin Tan Philip Philip Eileen M O'Reilly Anthony F Shields Shuji Ogino Charles S Fuchs Jeffrey A Meyerhardt
- Networks:
- HEARTLAND, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, OH027
- Study
- Alliance-A151939
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80702
- Phases:
- N/A, 3
- Keywords: